Home/Pipeline/Versius / Versius Plus Surgical System

Versius / Versius Plus Surgical System

Soft Tissue Minimal Access Surgery

CommercialActive

Key Facts

Indication
Soft Tissue Minimal Access Surgery
Phase
Commercial
Status
Active
Company

About CMR Surgical

CMR Surgical is on a mission to transform surgery globally by making robotic-assisted minimal access surgery more accessible to hospitals and patients. Founded in 2014 and headquartered in Cambridge, UK, the company has developed the Versius and next-generation Versius Plus systems, which are modular, portable, and designed to fit flexibly into existing operating rooms without requiring dedicated space. With recent FDA clearance for the U.S. market and over $200 million in new funding secured in 2025, CMR is positioned as a key challenger in the soft-tissue surgical robotics space, aiming to disrupt the status quo through its adaptable technology and partnership-focused approach.

View full company profile